Aflac Inc. (NYSE:AFL) – Equities research analysts at FBR & Co lowered their FY2017 earnings estimates for Aflac in a research report issued to clients and investors on Tuesday. FBR & Co analyst R. Binner now expects that the firm will earn $7.00 per share for the year, down from their prior forecast of $7.05. FBR & Co has a “Hold” rating on the stock.
Aflac (NYSE:AFL) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.71 EPS for the quarter, topping the consensus estimate of $1.68 by $0.03. The firm had revenue of $5.44 billion for the quarter, compared to the consensus estimate of $5.45 billion. Aflac had a net margin of 12.12% and a return on equity of 14.30%. The business’s revenue was up 2.8% compared to the same quarter last year. During the same period last year, the firm posted $1.50 earnings per share.
Other equities research analysts have also issued reports about the stock. Vetr lowered shares of Aflac from a “hold” rating to a “sell” rating and set a $70.50 target price for the company. in a report on Tuesday, July 12th. Zacks Investment Research lowered shares of Aflac from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Deutsche Bank AG reissued a “hold” rating and issued a $73.00 target price (down from $75.00) on shares of Aflac in a report on Monday, August 1st. Evercore ISI began coverage on shares of Aflac in a report on Wednesday, July 6th. They issued a “sell” rating and a $63.00 target price for the company. Finally, Wells Fargo & Co. began coverage on shares of Aflac in a report on Friday, September 23rd. They issued a “market perform” rating for the company. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $70.21.
Shares of Aflac (NYSE:AFL) traded up 0.41% on Wednesday, hitting $70.59. 1,549,484 shares of the company traded hands. Aflac has a 1-year low of $54.57 and a 1-year high of $74.50. The stock has a market capitalization of $28.91 billion, a price-to-earnings ratio of 11.61 and a beta of 1.33. The firm’s 50 day moving average price is $72.27 and its 200-day moving average price is $70.65.
In other Aflac news, insider Audrey B. Tillman sold 18,856 shares of the stock in a transaction on Monday, September 12th. The stock was sold at an average price of $73.50, for a total value of $1,385,916.00. Following the sale, the insider now owns 43,087 shares in the company, valued at $3,166,894.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Audrey B. Tillman sold 1,500 shares of the stock in a transaction on Tuesday, August 30th. The stock was sold at an average price of $73.98, for a total value of $110,970.00. Following the completion of the sale, the insider now owns 33,958 shares in the company, valued at approximately $2,512,212.84. The disclosure for this sale can be found here. 3.90% of the stock is owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in AFL. UBS Asset Management Americas Inc. raised its stake in Aflac by 5.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,463,721 shares of the company’s stock worth $155,559,000 after buying an additional 121,099 shares during the last quarter. Optimum Investment Advisors acquired a new stake in Aflac during the first quarter worth $222,000. Meeder Asset Management Inc. raised its stake in Aflac by 405.5% in the first quarter. Meeder Asset Management Inc. now owns 19,266 shares of the company’s stock worth $1,216,000 after buying an additional 15,455 shares during the last quarter. Rafferty Asset Management LLC raised its stake in Aflac by 159.1% in the first quarter. Rafferty Asset Management LLC now owns 99,465 shares of the company’s stock worth $6,280,000 after buying an additional 61,077 shares during the last quarter. Finally, Cypress Wealth Advisors LLC raised its stake in Aflac by 2.7% in the first quarter. Cypress Wealth Advisors LLC now owns 4,340 shares of the company’s stock worth $274,000 after buying an additional 114 shares during the last quarter. Institutional investors and hedge funds own 62.87% of the company’s stock.
Aflac Company Profile
Aflac Incorporated is a business holding company. The Company engaged in is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac’s insurance business consists of two segments: Aflac Japan and Aflac U.S.
Receive News & Ratings for Aflac Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Inc. and related companies with MarketBeat.com's FREE daily email newsletter.